Advertisement
Canada markets open in 8 hours 37 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7304
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     
  • Bitcoin CAD

    88,064.54
    -3,669.62 (-4.00%)
     
  • CMC Crypto 200

    1,389.02
    -35.08 (-2.46%)
     
  • GOLD FUTURES

    2,326.00
    -12.40 (-0.53%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,460.25
    -204.25 (-1.16%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    37,703.07
    -757.01 (-1.97%)
     
  • CAD/EUR

    0.6817
    -0.0002 (-0.03%)
     

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Lucira Health, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - December 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lucira Health, Inc. ("Lucira" or "the Company") (NASDAQ: LHDX) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Lucira issued a press release during pre-market hours on October 8, 2021. The Company disclosed that its partner Copan Italia SPA announced a recall of FLOQSwabs which were included in the Company's LUCIRA COVID-19 All-In-One Test Kit and LUCIRA CHECK IT COVID-19 Test Kit. The Company added, "according to Lucira's records, Test Kits containing the recalled Copan swabs were distributed from April 22, 2021 through September 22, 2021," and indicated that consumers should dispose of the Copan swabs. Based on this news, shares of Lucira dropped sharply on the same day.

If you are a shareholder who suffered a loss, click here to participate.

ADVERTISEMENT

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/106620